CTOs on the Move


 
Jems is a Orion, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Ansell

Ansell is a world leader in providing superior health and safety protection solutions that enhance human well-being. With operations in North America, Latin America/Caribbean, EMEA and Asia, Ansell employs more than 15,000 people worldwide and holds leading positions in the personal protective equipment and medical gloves market, as well as in the sexual health and well-being category worldwide. Ansell operates in four main business segments: Medical, Industrial, Single Use and Sexual Wellness. Our mission is to create a world where people and products enjoy optimal protection Ansell has four main operational headquarters in Iselin, NJ, USA, Brussels, Belgium, and CyberJaya, Malaysia, and its registered office is in Melbourne, Australia. Ansell Limited is a public Australian Company with its listing on the Australian Stock Exchange (ASX:ANN).

Blue Water Medical

Blue Water Medical is a Gulf Shores, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rusch Anesthesiology

Rusch Anesthesiology is a Research Triangle Park, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gericare Medical Supply

Gericare Medical Supply is a Monroeville, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RenalGuard Solutions

Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.